Wilson's disease care in Upper Egypt
Part of Brain & nervous system, Digestive system, Genetic & congenital, Hormones & metabolism clinical trials.
This study looks at how to improve care for people with Wilson's disease in a low-resource setting. It checks their diet, mental health, and where they live, aiming to create a support plan for patients in Upper Egypt.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 12 years old or older.
- You must have a confirmed diagnosis of Wilson's disease.
- You must be getting regular care at the Assiut Liver Center or the Wilson's Clinic.
- You must be feeling well enough to talk or fill out a survey.
- You must not be in the middle of a severe liver or nerve crisis.
- You must be able to understand and agree to take part.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people who have the genetic cause of Wilson disease, including people who feel well and family members. Researchers want to better understand Wilson disease and what to watch for over time.
This trial is a patient registry that collects health information from people with Wilson’s disease, including those without symptoms yet and those taking any type of treatment. It helps researchers understand the disease and how it progresses, which can support future studies and care improvements.
This early-stage trial tests LY-M003, a new gene therapy treatment for Wilson's disease—a rare genetic condition where copper builds up in the body. The study aims to see if this injection is safe and whether it can help patients who are already on standard copper-lowering medicines.
This study looks at how Wilson's disease might affect hormone levels in children. It aims to understand if the disease or its treatment can cause endocrine problems.
This trial is testing an experimental gene therapy called PM577 that aims to fix the faulty gene causing Wilson disease. It might offer a new treatment option that could reduce or replace the need for daily medications.
This study measures how much copper is present in breast milk in people with Wilson’s disease. It aims to provide safer guidance for breastfeeding during treatment, including during pregnancy.
Hear when a new Wilson's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.